Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Prior, S. (Sandra) | |
dc.creator | Gander, B. (Bruno) | |
dc.creator | Lecaroz, M.C. (María Concepción) | |
dc.creator | Irache, J.M. (Juan Manuel) | |
dc.creator | Gamazo, C. (Carlos) | |
dc.date.accessioned | 2011-10-22T17:18:04Z | - |
dc.date.available | 2011-10-22T17:18:04Z | - |
dc.date.issued | 2004 | - |
dc.identifier.citation | Prior S, Gander B, Lecaroz C, Irache JM, Gamazo C. Gentamicin-loaded microspheres for reducing the intracellular brucella abortus load in infected monocytes. J Antimicrob Chemother. 2004 Jun;53(6):981-8. | es_ES |
dc.identifier.issn | 0305-7453 | - |
dc.identifier.uri | https://hdl.handle.net/10171/19188 | - |
dc.description.abstract | Objectives: The intracellular antibiotic efficiency of gentamicin-loaded microspheres in the context of Brucella-infected murine monocytes was examined in vitro with a view to developing improved therapies for the treatment of brucellosis. Methods: Biodegradable microspheres made of end-group capped and uncapped poly(lactide-co-glycolide) 50:50 (PLGA 50:50 and PLGA 50:50H) and containing gentamicin sulphate were used to target Brucella abortus-infected J774 monocyte-macrophages. The infected cells were treated with 15 µg of free or microencapsulated gentamicin and the efficacy of the treatments was measured after 24 h. Results: The particle sizes were below 8 µm and in vitro release of gentamicin from the microspheres followed a continuous (PLGA 50:50H) or a multiphasic (PLGA 50:50) pattern over 50 days. Treatment with gentamicin microencapsulated into the end-group uncapped PLGA 50:50H microspheres, decreased significantly the number of intracellular bacteria (typically by 2 log10) in comparison with untreated infected cells. Addition of 2% poloxamer 188 to the microsphere dispersion medium further reduced the infection (3.5 log10). Opsonization of the particles with non-immune mouse serum had no effect on the antibacterial efficacy of the microspheres. End-group capped PLGA 50:50 type microspheres containing the antibiotic were less effective at reducing intracellular bacteria (∼1 log10 reduction), although addition of poloxamer 188 to the dispersion medium again enhanced their intracellular antibacterial activity. Placebo PLGA 50:50 and PLGA 50:50H microspheres had no bactericidal activity. Conclusions: The results indicate that PLGA 50:50-microencapsulated gentamicin sulphate may be suitable for efficient drug targeting and delivery to reduce intracellular Brucella infections. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Oxford University Press | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Biodegradable microspheres | es_ES |
dc.subject | Drug delivery systems | es_ES |
dc.subject | Brucella-infected monocytes | es_ES |
dc.title | Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.identifier.doi | http://dx.doi.org/10.1093/jac/dkh227 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.